Israel Discount Bank of New York’s AbbVie ABBV Stock Holding History

Israel Discount Bank of New York’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-159	Closed	-$13K	–	81
2019 Q1	$13K	Hold	159	–	–	0.01%	361
2018 Q4	$15K	Buy	159 +20	+14%	+$1.76K	0.01%	352
2018 Q3	$13K	Sell	139 -20	-13%	-$1.9K	0.01%	366
2018 Q2	$15K	Hold	159	–	–	0.01%	372
2018 Q1	$15K	Hold	159	–	–	0.01%	375
2017 Q4	$15K	Sell	159 -100	-39%	-$9.43K	0.01%	380
2017 Q3	$23K	Hold	259	–	–	0.02%	363
2017 Q2	$19K	Hold	259	–	–	0.02%	369
2017 Q1	$17K	Sell	259 -200	-44%	-$12.6K	0.01%	383
2016 Q4	$29K	Buy	+459	New	+$28K	0.03%	360

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Israel Discount Bank of New York's ABBV Position: Q2 2019 in Review

Israel Discount Bank of New York sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 159 shares — an estimated $13K sold.

Israel Discount Bank of New York first reported a position in ABBV in Q4 2016 and held it in 10 quarters. The position peaked at $29K in Q4 2016. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Israel Discount Bank of New York reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
Israel Discount Bank of New York sold 159 AbbVie shares in Q2 2019, an estimated $13K.
Israel Discount Bank of New York first reported a position in AbbVie in Q4 2016 and held it in 10 quarters.
Israel Discount Bank of New York's AbbVie position peaked at $29K in Q4 2016.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Israel Discount Bank of New York's 13F filing for Q2 2019, filed 14 Aug 2019.